Phase 3 Results of Donanemab, an Alzheimer's drug, are promising.

Published Date: 18 Jul 2023

In a phase 3 trial, patients with early Alzheimer's disease who received the monoclonal antibody donanemab experienced a 35% slower rate of clinical and functional decline. The medication did have some safety concerns, though.

Read Full News

Latest News

'Just Bloating': Stop Dismissing This Common GI Complaint

Bloating is one of patients' most common gastrointestinal complaints. Dr Alicia Muratore kicks off this six-part series by asking why bloating is often treated as an afterthought.

S1 Episode 4: Urinary Tract Infections and Sexual Function

Drs Anne Lenore Ackerman and Rachel S. Rubin discuss urinary tract infections, sexual function, quality of life, and the importance of patient education.

Immunotherapy Promises New Era in Cancer Prevention

Prof David Kerr explores whether PD-1 inhibitors and targeted vaccines can regress polyps and prevent secondary cancers in Lynch syndrome.

HF Hospitalizations and Telehealth Coverage Parity Laws

State telehealth coverage parity laws require private insurers to cover outpatient telehealth visits increasing access for HF patients. This analysis examines whether this affected clinical outcomes.

How Young Adults Are Redefining Trust in Healthcare

Gen Z often turns to AI, social media, and their own research before seeing a physician. Here, young adults share their views on trust, healthcare, and where they seek answers on health concerns.

Minor Hallucinations Distinguish Early DLB From AD

Minor hallucinations and pareidolic responses differentiate early dementia with Lewy bodies from AD, a study shows.

Todays Updates

Hyponatremia Risk Varies Among Second-Gen Antipsychotics

Aripiprazole is associated with a lower risk for hyponatremia compared with olanzapine in patients treated with second-generation antipsychotics, a new cohort study shows.

HCT Survival Outcomes Improving in Relapsed Hodgkin Lymphoma

Researchers evaluate changes in post-transplantation outcomes among patients with relapsed or refractory Hodgkin lymphoma from 2010 to 2022.

How Much of a Cancer Drug Is Too Much?

In a recent KFF survey, 43% of US adults said they had skipped their medication in the past year because of cost.

Todays Updates

Hyponatremia Risk Varies Among Second-Gen Antipsychotics

Aripiprazole is associated with a lower risk for hyponatremia compared with olanzapine in patients treated with second-generation antipsychotics, a new cohort study shows.

HCT Survival Outcomes Improving in Relapsed Hodgkin Lymphoma

Researchers evaluate changes in post-transplantation outcomes among patients with relapsed or refractory Hodgkin lymphoma from 2010 to 2022.

How Much of a Cancer Drug Is Too Much?

In a recent KFF survey, 43% of US adults said they had skipped their medication in the past year because of cost.

Latest News

Bloating is one of patients' most common gastrointestinal complaints. Dr Alicia Muratore kicks off this six-part series by asking why bloating is often treated as an afterthought.

Drs Anne Lenore Ackerman and Rachel S. Rubin discuss urinary tract infections, sexual function, quality of life, and the importance of patient education.

Prof David Kerr explores whether PD-1 inhibitors and targeted vaccines can regress polyps and prevent secondary cancers in Lynch syndrome.

State telehealth coverage parity laws require private insurers to cover outpatient telehealth visits increasing access for HF patients. This analysis examines whether this affected clinical outcomes.

Gen Z often turns to AI, social media, and their own research before seeing a physician. Here, young adults share their views on trust, healthcare, and where they seek answers on health concerns.

Minor hallucinations and pareidolic responses differentiate early dementia with Lewy bodies from AD, a study shows.

News All Time

Bariatric Same-Day Discharge Criteria Lack Consensus

A systematic review finds that most studies on same-day discharge after bariatric surgery use inconsistent patient selection and discharge definitions, preventing reliable evidence synthesis.

Digital Health: Is Innovation Widening the Equity Gap?

Digital health can improve access, but gaps in technology, digital skills, and infrastructure may leave vulnerable groups behind as adoption expands across healthcare.

Case of a Man With Subclavian Steal Syndrome

A man with arm pain, asymmetric blood pressure, and weakness was found to have overlapping vascular and cervical spine disease complicating the diagnosis.

What Influencers Get Wrong about Diet and Gut Health

Your patients hear these claims online. Here's what the evidence actually shows.

The Challenge of Diagnosing ADHD in Adults

Inattention doesn't necessarily mean ADHD. Dr Zebib Abraham explains the complexities of evaluating adults and what clinicians should consider before making a diagnosis.

Navigating Cancer Screening Without the USPSTF

Without USPSTF guidance, how should primary care approach cancer screening? Dr Kenny Lin reviews key updates in cervical, colorectal, and lung cancer protocols.

Telemedicine Remains Relevant in Pediatric Care

The use of telemedicine in child primary care reduces from pandemic highs to 6% by 2024.

Patient Warning: Bariatric Surgery Can Get Them Drunk Faster

‘The same amount of alcohol may produce at least twice the effect,’ experts say. Patients need early education on the situation.

Does Transabdominal Cerclage Affect Quality of Life?

The placement of a permanent transabdominal cerclage does not appear to compromise health-related quality of life.

Signaling, Data, and Transparency Improve Match-Matching

Medical students filed fewer residency applications this year, but the rate of successful matches is nearly 100%. Here’s why.

20-Year Study Ties Nitrites to Colon Cancer, in Men Only

Men with higher estimated nitrite intake from meat, vegetables, and drinking water have an increased risk for colorectal cancer, especially in the distal colon.

GLP-1 Patient With a Belching Problem? Singing May Help

Some research shows patients on GLP-1 have a particular problem with belching. One trial found singing may actually help.

Glofitamab-GemOx Shows Sustained Survival Benefit in DLBCL

Three-year STARGLO data show longer survival with glofitamab-GemOx vs rituximab-GemOx in ASCT-ineligible patients with relapsed or refractory DLBCL.

Watchful Waiting Effective for Mild-to-Moderate OSA in Kids

About half of young children with mild-to-moderate obstructive sleep apnea experienced spontaneous resolution without surgery, a study shows.

Overheard in Medicine: Are Patients in Your DMs?

Overhead in Medicine is a Medscape digest that surfaces a few of the week’s top posts from major medical subreddits.

Adapting Approaches in the Fibromyalgia Landscape

Dr Andrea Chadwick describes how the shift from tender points to symptom-based criteria has improved fibromyalgia diagnosis, understanding, and patient-centered care.

Recommended News For You

Despite Medicare Coverage, Cancer Genomic Testing Still Low

Where Does Mistletoe Extract Fit in Supportive Cancer Care?

Unexplained CAR-T Death; Americans Spurn Sunscreen; Improving Diversity in Trials

What is a "cancer vaccine" and is it the same as a COVID vaccine?

A smartphone app enhances the tracking of recovery following breast and gynecologic oncology surgery, according to JAMA.

'Chemo brain' cognitive issues linked to poor lymphatic-system drainage

Retifanlimab-Chemo Combo Boosts PFS in Advanced Squamous Cell Anal Cancer

Recommended Articles For You

Omega-3 Fatty Acids as Molecular Adjuvants Against Chemoresistance in Breast Cancer 

Understanding Evans Syndrome: Causes, Symptoms, and Treatment Options  

Mechanistic Depth and Clinical Impact of Rusfertide, Onyvide, IV Avastin, and Pemfexy 

Beyond Symptoms: The Predictive Promise of Targeted Radionuclide Therapy in Palliative Oncology 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

A BRAF V600E mutation-positive intrathoracic synovial sarcoma is reported by researchers.

2.

No Survival Gain With Preoperative CRT Plus Perioperative Chemo for Gastric Cancer

3.

Innovative oncology therapeutics are being created in collaboration between Moderna and Immatics.

4.

An inoperable locally advanced NSCLC trial dubbed "Practice Changing".

5.

CDC Alerts on Dramatic Rise in Human Parvovirus B19

1.

All You Need To Know About Partial Thromboplastin Time (PTT) Test

2.

Machine Learning in Genomic Analysis for Early Lung Cancer Detection: Key Advances and Insights

3.

Survivin as a Key Regulator in Gynecological Cancers: Therapeutic and Prognostic Implications

4.

Rasburicase-Linked Methemoglobinemia in HCC: Risks, Mechanisms, and Management

5.

Unleashing the Inner Predator: Reprogramming Macrophages to Conquer Cancer Immunotherapy

1.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

2.

International Cancer Conference

3.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

4.

Asian Symposium on Advancement in Hematology and Oncology

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)

2.

Navigating the Complexities of Ph Negative ALL - Part IV

3.

Recent Data Analysis for First-Line Treatment of ALK+ NSCLC

4.

Newer Immunotherapies for Myeloma- A Comprehensive Overview

5.

Navigating the Complexities of Ph Negative ALL - Part XII

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot